These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 7522624)
1. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK Blood; 1994 Oct; 84(7):2305-14. PubMed ID: 7522624 [TBL] [Abstract][Full Text] [Related]
2. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881 [TBL] [Abstract][Full Text] [Related]
3. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508 [TBL] [Abstract][Full Text] [Related]
4. The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells. Gruss HJ; Scheffrahn I; Hubinger G; Duyster J; Hermann F Leukemia; 1996 May; 10(5):829-35. PubMed ID: 8656679 [TBL] [Abstract][Full Text] [Related]
5. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986 [TBL] [Abstract][Full Text] [Related]
6. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051 [TBL] [Abstract][Full Text] [Related]
7. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells. Gruss H-J ; Herrmann F Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395 [TBL] [Abstract][Full Text] [Related]
8. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma. Kim LH; Eow GI; Peh SC; Poppema S Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388 [TBL] [Abstract][Full Text] [Related]
10. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. Yellin MJ; Brett J; Baum D; Matsushima A; Szabolcs M; Stern D; Chess L J Exp Med; 1995 Dec; 182(6):1857-64. PubMed ID: 7500031 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Wolf J; Kapp U; Bohlen H; Kornacker M; Schoch C; Stahl B; Mücke S; von Kalle C; Fonatsch C; Schaefer HE; Hansmann ML; Diehl V Blood; 1996 Apr; 87(8):3418-28. PubMed ID: 8605360 [TBL] [Abstract][Full Text] [Related]
12. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance. Clodi K; Asgari Z; Younes M; Palmer JL; Cabanillas F; Carbone A; Andreeff M; Younes A Cancer; 2002 Jan; 94(1):1-5. PubMed ID: 11815953 [TBL] [Abstract][Full Text] [Related]
13. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease. Gruss HJ; Duyster J; Herrmann F Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404 [TBL] [Abstract][Full Text] [Related]
14. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease. Van Gool SW; Delabie J; Vandenberghe P; Coorevits L; De Wolf-Peeters C; Ceuppens JL Leukemia; 1997 Jun; 11(6):846-51. PubMed ID: 9177439 [TBL] [Abstract][Full Text] [Related]
15. Costimulatory molecules (CD80 and CD86) on Reed-Sternberg cells are associated with the proliferation of background T cells in Hodgkin's disease. Nozawa Y; Wakasa H; Abe M Pathol Int; 1998 Jan; 48(1):10-4. PubMed ID: 9589458 [TBL] [Abstract][Full Text] [Related]
16. The role of eosinophils in the pathobiology of Hodgkin's disease. Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Perin V; Todesco M; De Iuliis A; Improta S; Sacco C; Gattei V; Gruss HJ; Carbone A Ann Oncol; 1997; 8 Suppl 2():89-96. PubMed ID: 9209649 [TBL] [Abstract][Full Text] [Related]
17. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas. Hsu SM; Waldron J; Xie SS; Hsu PL J Biomed Sci; 1995 Oct; 2(4):302-313. PubMed ID: 11725067 [TBL] [Abstract][Full Text] [Related]
18. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma. Hsu PL; Hsu SM Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157 [TBL] [Abstract][Full Text] [Related]
19. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Fiumara P; Snell V; Li Y; Mukhopadhyay A; Younes M; Gillenwater AM; Cabanillas F; Aggarwal BB; Younes A Blood; 2001 Nov; 98(9):2784-90. PubMed ID: 11675352 [TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]